课题基金 / 基金详情

Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)

Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)
罕见疾病临床研究联盟 (RDCRC) 的罕见疾病临床研究网络 (U54)
批准号:
9145795
负责人:
MICHIO HIRANO
金额:
$24.85万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2019-08-31

项目摘要

项目成果

MICHIO HIRANO的其他基金

相似基金

相关文献

中文摘要
翻译
为了收集有关线粒体疾病的广泛信息,NAMDC设计了和
英文摘要
To collect information about the wide spectrum of mitochondrial diseases, NAMDC has designed and implemented a comprehensive mitochondrial disease Clinical Registry, which gathers baseline clinical, biochemical, and molecular genetic data as well as tracks the natural histories of the patients through the NAMDC Clinical Longitudinal study. The overall missions of the NAMDC Clinical Registry are to: better understand the spectrum and overlap of phenotypes for specific mitochondrial diseases; enable genotype/phenotype correlations; facilitate enrollment into clinical studies under NAMDC arid other entities; and characterize the natural histories of mitochondrial diseases. More than 425 patients have been enrolled across 13 NAMDC sites in collaboration with the United Mitochondrial Disease Foundation (UMDF). We have also created NAMDC Research Diagnostic Criteria for mitochondrial diseases with strict benchmarks for definite, probable, possible, or unlikely levels of diagnoses. Samples of blood, skin, and other tissues are being deposited into the NAMDC Biorepository housed at the Mayo Clinic under the direction of Dr. Devin Oglesbee. The NAMDC Clinical Registry, Research Diagnostic Criteria, and Biorepository are three pillars that form a strong foundation for multi-center collaborative mitochondrial disease research. From this firm base, productive patient-oriented projects have already sprouted; natural history studies on mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), Alpers disease, and Pearson syndrome have been initiated by NAMDC site investigators. This project seeks: to expand the NAMDC Clinical Registry and Biorepository; to continue to on-going natural history studies including the Clinical Longitudinal study, to apply and refine the NAMDC Research Diagnostic Criteria; to support the MNGIE AHSCT Safety Study (MASS, Project 2); to strengthen links to mitochondrial disease sequence data resource (MSeqDR) consortium; and to support new research projects including the "Natural History and Advanced Genetic Studies of PDC Deficiency" (Project 3); and the studies of nutritional supplements for mitochondrial diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)
NAMDC: Overall Research Plan
国内基金
海外基金
Perry syndrome相关蛋白p150glued调控黑质多巴胺能神经元功能和变性的机制
  • 批准号:
    81601117
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2016
  • 负责人:
    于佳
  • 依托单位:
天使症候群(Angelman Syndrome,AS)TrkB信号损伤的机制研究及靶向干预
  • 批准号:
    31371139
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    曹聪
  • 依托单位:
p73在Hutchinson-Gilford Progeria Syndrome 中对DNA损伤修复通路调控的机制研究
  • 批准号:
    81300258
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    汤慧
  • 依托单位:
新的Peutz-Jeghers Syndrome 致病基因的定位与克隆
  • 批准号:
    30240062
  • 项目类别:
    专项基金项目
  • 资助金额:
    7.0万元
  • 批准年份:
    2002
  • 负责人:
    李宜雄
  • 依托单位: